Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori

dc.contributor.authorBor S.
dc.contributor.authorKitapcioglu G.
dc.contributor.authorKasap E.
dc.date.accessioned2024-07-22T08:10:58Z
dc.date.available2024-07-22T08:10:58Z
dc.date.issued2017
dc.description.abstractAIM: To evaluate the prevalence of gastroesophageal reflux disease (GERD) with additional symptoms, relationship with Helicobacter pylori (H. pylori) of this country-wide study. METHODS: Data from 3214 adults were obtained with validated questionnaire. Eight hundred and forty-one subjects were randomized to be tested for H. pylori via the urea breath test. "Frequent symptoms" were defined heartburn and/or regurgitation occurring at least weekly. RESULTS: The prevalence of GERD was 22.8%, frequent and occasional heartburn were 9.3%-12.7%, regurgitation were 16.6%-18.7%, respectively. Body mass index (BMI) ≤ 18.5 showed a prevalence of 15%, BMI > 30 was 28.5%. The GERD prevalence was higher in women (26.2%) than men (18.9%) (P < 0001). Overall prevalence of H. pylori was 75.7%. The prevalence was 77.1% in subjects without symptoms vs 71.4% in subjects with GERD (χ2 = 2.6, P = 0.27). Underprivileged with the lowest income people exhibit a higher risk. CONCLUSION: GERD is common in Turkey which reflects both Western and Eastern lifestyles with high rate of H. pylori. The presence of H. pylori had no effect on either the prevalence or the symptom profile of GERD. Subjects showing classical symptoms occasionally exhibit more additional symptoms compared with those without classical symptoms. © 2017 Baishideng Publishing Group Inc. All rights reserved.
dc.identifier.DOI-ID10.3748/wjg.v23.i3.525
dc.identifier.issn10079327
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15466
dc.language.isoEnglish
dc.publisherBaishideng Publishing Group Co
dc.rightsAll Open Access; Green Open Access; Hybrid Gold Open Access
dc.subjectAdult
dc.subjectBreath Tests
dc.subjectFemale
dc.subjectGastroesophageal Reflux
dc.subjectHeartburn
dc.subjectHelicobacter Infections
dc.subjectHelicobacter pylori
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPrevalence
dc.subjectRandom Allocation
dc.subjectSurveys and Questionnaires
dc.subjectTurkey
dc.subjectUrea
dc.subjectalginic acid
dc.subjectantacid agent
dc.subjecthistamine H2 receptor antagonist
dc.subjectnonsteroid antiinflammatory agent
dc.subjectproton pump inhibitor
dc.subjecturea
dc.subjectadult
dc.subjectArticle
dc.subjectasthma
dc.subjectbody mass
dc.subjectcoughing
dc.subjectdyspepsia
dc.subjectdysphagia
dc.subjecteructation
dc.subjectfemale
dc.subjectgastroesophageal reflux
dc.subjectheartburn
dc.subjectHelicobacter pylori
dc.subjecthematemesis
dc.subjecthiccup
dc.subjecthoarseness
dc.subjecthuman
dc.subjectlowest income group
dc.subjectmale
dc.subjectnausea
dc.subjectnoncardiac chest pain
dc.subjectodynophagia
dc.subjectpharyngitis
dc.subjectprevalence
dc.subjectsex ratio
dc.subjectTurk (people)
dc.subjecturea breath test
dc.subjectvomiting
dc.subjectbreath analysis
dc.subjectgastroesophageal reflux
dc.subjectheartburn
dc.subjectHelicobacter Infections
dc.subjectHelicobacter pylori
dc.subjectisolation and purification
dc.subjectmicrobiology
dc.subjectmiddle aged
dc.subjectquestionnaire
dc.subjectrandomization
dc.subjectTurkey
dc.titlePrevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori
dc.typeArticle

Files